Karuna Therapeutics, Inc. Operating Income
Karuna Therapeutics, Inc. reported Operating Income of -$494.78 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2024-02-22
- Karuna Therapeutics, Inc. operating income (loss) for the quarter ending 2023-12-31 was -$129.59M.
- Karuna Therapeutics, Inc. operating income (loss) for the quarter ending 2023-09-30 was -$136.22M.
- Karuna Therapeutics, Inc. operating income (loss) for the quarter ending 2023-06-30 was -$119.91M.
- Karuna Therapeutics, Inc. operating income (loss) for the quarter ending 2023-03-31 was -$109.07M.
- Karuna Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$494.78M.
- Karuna Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$289.68M.
- Karuna Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$143.85M.
- Karuna Therapeutics, Inc. operating income (loss) for fiscal 2020 was -$71.82M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$129.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$265.80M derived: sum of 2 quarters · filed 2024-02-22 | -$385.71M derived: sum of 3 quarters · filed 2024-02-22 | -$494.78M 10-K · filed 2024-02-22 |
| 2023-09-30 | -$136.22M 10-Q · filed 2023-11-02 | -$256.13M derived: sum of 2 quarters · filed 2023-11-02 | -$365.19M 10-Q · filed 2023-11-02 | -$450.23M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-06-30 | -$119.91M 10-Q · filed 2023-08-03 | -$228.97M 10-Q · filed 2023-08-03 | -$314.01M derived: sum of 3 quarters · filed 2024-02-22 | -$395.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-03-31 | -$109.07M 10-Q · filed 2023-05-04 | -$194.10M derived: sum of 2 quarters · filed 2024-02-22 | -$275.10M derived: sum of 3 quarters · filed 2024-02-22 | -$340.15M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-12-31 | -$85.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$166.03M derived: sum of 2 quarters · filed 2024-02-22 | -$231.08M derived: sum of 3 quarters · filed 2024-02-22 | -$289.68M 10-K · filed 2024-02-22 |
| 2022-09-30 | -$80.99M 10-Q · filed 2023-11-02 | -$146.05M derived: sum of 2 quarters · filed 2023-11-02 | -$204.64M 10-Q · filed 2023-11-02 | -$232.83M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$65.05M 10-Q · filed 2023-08-03 | -$123.65M 10-Q · filed 2023-08-03 | -$151.84M derived: sum of 3 quarters · filed 2024-02-22 | -$203.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$58.59M 10-Q · filed 2023-05-04 | -$86.78M derived: sum of 2 quarters · filed 2024-02-22 | -$137.95M derived: sum of 3 quarters · filed 2024-02-22 | -$172.48M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$28.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$79.36M derived: sum of 2 quarters · filed 2024-02-22 | -$113.89M derived: sum of 3 quarters · filed 2024-02-22 | -$143.85M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$51.17M 10-Q · filed 2022-11-03 | -$85.70M derived: sum of 2 quarters · filed 2022-11-03 | -$115.66M 10-Q · filed 2022-11-03 | -$140.07M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$34.53M 10-Q · filed 2022-08-08 | -$64.49M 10-Q · filed 2022-08-08 | -$88.90M derived: sum of 3 quarters · filed 2023-02-23 | -$108.43M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$29.96M 10-Q · filed 2022-05-05 | -$54.37M derived: sum of 2 quarters · filed 2023-02-23 | -$73.90M derived: sum of 3 quarters · filed 2023-02-23 | -$91.72M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$24.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$43.94M derived: sum of 2 quarters · filed 2023-02-23 | -$61.76M derived: sum of 3 quarters · filed 2023-02-23 | -$71.82M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$19.53M 10-Q · filed 2021-11-04 | -$37.35M derived: sum of 2 quarters · filed 2021-11-04 | -$47.41M 10-Q · filed 2021-11-04 | -$56.27M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$17.82M 10-Q · filed 2021-08-05 | -$27.88M 10-Q · filed 2021-08-05 | -$36.75M derived: sum of 3 quarters · filed 2022-02-24 | -$46.64M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$10.05M 10-Q · filed 2021-05-06 | -$18.92M derived: sum of 2 quarters · filed 2022-02-24 | -$28.82M derived: sum of 3 quarters · filed 2022-02-24 | -$43.89M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$8.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$18.76M derived: sum of 2 quarters · filed 2022-02-24 | -$33.83M derived: sum of 3 quarters · filed 2022-02-24 | -$45.41M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$9.90M 10-Q · filed 2020-11-05 | -$24.97M derived: sum of 2 quarters · filed 2020-11-05 | -$36.54M 10-Q · filed 2020-11-05 | -$44.69M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$15.07M 10-Q · filed 2020-08-05 | -$26.64M 10-Q · filed 2020-08-05 | -$34.79M derived: sum of 3 quarters · filed 2021-02-25 | -$37.26M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$11.57M 10-Q · filed 2020-05-07 | -$19.72M derived: sum of 2 quarters · filed 2021-02-25 | -$22.19M derived: sum of 3 quarters · filed 2021-02-25 | -$24.62M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$8.15M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$10.62M derived: sum of 2 quarters · filed 2021-02-25 | -$13.05M derived: sum of 3 quarters · filed 2021-02-25 | -$14.51M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$2.47M 10-Q · filed 2019-11-07 | -$4.90M derived: sum of 2 quarters · filed 2019-11-07 | -$6.36M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$2.43M 10-Q · filed 2019-08-08 | -$3.89M 10-Q · filed 2019-08-08 |